MAX-Pharmasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-03-04
Share capital
5,000.00 PLN
Registered address
ul. Żwirki I Wigury 16A/Biuro 315, 02-092 Warszawa, Poland
Electronic delivery address
AE:PL-39159-95789-AISAC-27

Financials

Revenue history (in m)

Financial insight

  • The statement flags a going concern risk. Na dzień 31 grudnia 2025 r. skumulowane straty wyniosły 41 712 280,57 zł i przewyższyły sumę kapitału zapasowego i kapitałów rezerwowych oraz połowę kapitału zakładowego o kwotę 41 709 780,57 zł. Stosownie do wymogów art. 233 ustawy z dnia 7.12.2023 r. KSH (Dz.U. z 2024 r. poz. 18) Nadzwyczajne Zgromadzenie Wspólników w dniu 6 marca 2026 podjęło uchwałę o kontynuowaniu działalności firmy.

From the notes

Current income tax (CIT due)$0

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 68 days for 2021). All were audited by a statutory auditor.

  • 202513/07/2026
  • 202416/07/2025
  • 202319/07/2024
  • 202219/09/2023
  • 202121/09/2022
  • 202008/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 2.0%
Division · Retail trade336 / 9,914
Top 3.4%
City · Warszawa1,591 / 56,958
Top 2.8%
Voivodeship · Mazowieckie2,124 / 77,118
Top 2.8%
Country · Poland6,819 / 297,873
Top 2.3%

Results vs industry

Revenue
This companyUSD 32.73mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -171.62kMedianUSD 20.70kAverageUSD 86.94k
Operating costs
This companyUSD 32.08mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 5.38mMedianUSD 543.65kAverageUSD 1.76m

Public procurement

MAX-Pharma is the contractor in 2 public sector contracts, worth USD 6.69k in total. They were signed with 2 public buyers.

SubjectAmount
Purchase of Combo and CRP tests
$226.80
Supply of medicines and small medical equipment for Dom Pomocy Społecznej w Teodorówce and its branches in Długi Kąt and Biłgoraj
$6,467

National Health Fund (NFZ) contracts

MAX-Pharma has been an NFZ healthcare provider since 2017. In 2026 it is performing 14 contracts with a total value of USD 823.88. All its contracts were worth USD 5.58k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmesmazowieckie1USD 364.67
Pilot programmeswarmińsko-mazurskie1USD 324.15
Pilot programmespomorskie1USD 135.06
Other services provided in pharmacieswarmińsko-mazurskie1USD 0.00
Provision of medical deviceskujawsko-pomorskie1USD 0.00

Authorized Representatives

Grzegorz Bajtała – President of the Management Board

Manner of representation

If the management board is a multi-member management board, joint action of two members of the management board, or one member of the management board together with a commercial proxy, is required to make declarations on behalf of the company. If the management board is a one-person management board, the President of the Management Board represents the company independently.

Ownership

OwnerSharesShare valueStake
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-09-23.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 280.8K

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cosmedicasp. z o.o.
DR ZdrowieS.A.
MagmaxS.A.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

Change history

DateEvent
2026-07-22PKD change
2023-11-08Address change
2023-11-08PKD change
2018-06-20Address change
2018-06-20PKD change

FAQ

Last updated: 2026-10-07